XML 27 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-based compensation
9 Months Ended
Sep. 30, 2017
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Share-based compensation

10. Share-based compensation

The following tables present the detail of share-based compensation by line item in the condensed consolidated statements of operations as well as by award type:

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

(U.S. Dollars, in thousands)

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Cost of sales

 

$

151

 

 

$

175

 

 

$

437

 

 

$

401

 

Sales and marketing

 

 

394

 

 

 

331

 

 

 

1,073

 

 

 

887

 

General and administrative

 

 

2,828

 

 

 

7,148

 

 

 

6,935

 

 

 

10,082

 

Research and development

 

 

259

 

 

 

488

 

 

 

679

 

 

 

784

 

 

 

$

3,632

 

 

$

8,142

 

 

$

9,124

 

 

$

12,154

 

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

(U.S. Dollars, in thousands)

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Stock options

 

$

684

 

 

$

425

 

 

$

1,802

 

 

$

1,367

 

Time-based restricted stock awards

 

 

1,552

 

 

 

1,840

 

 

 

4,083

 

 

 

4,278

 

Performance-based restricted stock awards

 

 

115

 

 

 

5,089

 

 

 

340

 

 

 

5,089

 

Performance-based and market-based restricted stock units

 

 

997

 

 

 

472

 

 

 

1,935

 

 

 

472

 

Stock purchase plan

 

 

284

 

 

 

316

 

 

 

964

 

 

 

948

 

 

 

$

3,632

 

 

$

8,142

 

 

$

9,124

 

 

$

12,154

 

The decreases in share-based compensation expense of $4.5 million and $3.0 million, respectively, for the three and nine months ended September 30, 2017, as compared to the prior period were primarily attributable to certain performance-based awards that were first determined to be probable to vest during the third quarter of 2016, resulting in additional expense of $5.1 million during the third quarter of 2016.

During the three months ended September 30, 2017 and 2016, the Company issued 93,486 and 181,235 shares, respectively, of common stock related to stock purchase plan issuances, stock option exercises and the vesting of restricted stock awards. During the nine months ended September 30, 2017 and 2016, the Company issued 384,761 and 710,026 shares, respectively, of common stock related to stock purchase plan issuances, stock option exercises and the vesting of restricted stock awards.